|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.27 CNY | +0.54% |
|
+1.53% | -16.11% |
| 14/05 | Zhejiang Jianfeng's Pharmaceutical Unit Gets Nod to Market Anti-Tumor Drug | MT |
| 07/05 | Jianfeng Group's Pharma Unit Gets Nod to Sell Glaucoma Eye Drops | MT |
Zhejiang Jianfeng Group Co., Ltd. reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 2,592 million compared to CNY 2,580.66 million a year ago. Net income was CNY 185.07 million compared to CNY 424.26 million a year ago.
Basic earnings per share from continuing operations was CNY 0.5379 compared to CNY 1.23 a year ago. Diluted earnings per share from continuing operations was CNY 0.5379 compared to CNY 1.23 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -16.11% | 44Cr | |
| +18.87% | 4.87TCr | |
| +19.73% | 1.75TCr | |
| -2.94% | 1.63TCr | |
| -8.19% | 1.11TCr | |
| +26.36% | 889.51Cr | |
| +45.17% | 790.28Cr | |
| -2.73% | 786.84Cr | |
| -1.05% | 774.01Cr | |
| +105.28% | 721.39Cr |
ZHEJIANG JIANFENG GROUP CO., LTD. 